Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Experimental Neurology|September 2, 2018
Commentary on Giralt et al.: PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's diseaseBaruh Polis, Hava Gil-HennJournal of Biological Methods|August 28, 2019
A guide to simple, direct, and quantitative <i>in vitro</i> binding assaysStefanie Lapetina, Hava Gil-HennThe Journal of Biological Chemistry|February 25, 2003
Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cellsHava Gil-Henn, Ari ElsonDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 5, 2018
Targeting invadopodia for blocking breast cancer metastasisTomer Meirson, Hava Gil-HennCells|August 27, 2021
Invadopodia, a Kingdom of Non-Receptor Tyrosine KinasesTrishna Saha, Hava Gil-HennMolecular & Cellular Oncology|September 26, 2018
FAK family kinases: The Yin and Yang of cancer cell invasivenessAlessandro Genna, Hava Gil-HennEuropean Journal of Cell Biology|May 29, 2012
Invadopodia: the leading forceHadas Sibony-Benyamini, Hava Gil-HennTrends in Cell Biology|August 16, 2023
PYK2, a hub of signaling networks in breast cancer progressionHava Gil-Henn, Jean-Antoine Girault, Sima LevDrug Design, Development and Therapy|June 3, 2017
An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2Tomer Meirson, Abraham O Samson, Hava Gil-HennJournal of Clinical Medicine|April 23, 2022
Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target ThemTrishna Saha Detroja, Hava Gil-Henn, Abraham O SamsonPageof 5